[1] SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] UHLENHOPP D J, THEN E O, SUNKARA T, et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors[J]. Clin J Gastroenterol, 2020, 13(6): 1010-1021. [3] FAN J H, LIU Z Q, MAO X H, et al. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017[J]. Cancer Med, 2020, 9(18): 6875-6887. [4] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [5] TANG W R, CHEN Z J, LIN K, et al. Development of esophageal cancer in Chaoshan region, China: association with environmental, genetic and cultural factors[J]. Int J Hyg Environ Health, 2015, 218(1): 12-18. [6] SAHMOUN A E, CASE L D, JACKSON S A, et al. Cadmium and prostate cancer: a critical epidemiologic analysis[J]. Cancer Invest, 2005, 23(3): 256-263. [7] FILIPPINI T, MICHALKE B, MALAGOLI C, et al. Determinants of serum cadmium levels in a Northern Italy community: a cross-sectional study[J]. Environ Res, 2016, 150: 219-226. [8] YU G G, ZHENG W R, WANG W, et al. Health risk assessment of Chinese consumers to Cadmium via dietary intake[J]. J Trace Elem Med Biol, 2017, 44: 137-145. [9] AUTHORITY E F S. Cadmium dietary exposure in the European population[J]. EFSA J, 2012, 10(1): 2551. [10] WANG M, SONG H, CHEN W Q, et al. Cancer mortality in a Chinese population surrounding a multi-metal sulphide mine in Guangdong Province: an ecologic study[J]. BMC Public Health, 2011, 11: 319. [11] 刘真群, 陈艳. 伊犁地区哈萨克族食管癌高低发区人体内外环境化学元素含量分析[J]. 新疆医科大学学报, 2012, 35(11): 1462-1467, 1472. [12] JIANG A L, GONG L J, DING H, et al. Cancer mortality and long-term environmental exposure of cadmium in contaminated community based on a third retrospective cause of death investigation of residents living in the Guangdong Province from 2004 to 2005[J]. Biol Trace Elem Res, 2021, 199(12): 4504-4515. [13] CHEN J Y, ZHOU Z Z, LIN X Q, et al. Environmental cadmium exposure promotes the development, progression and chemoradioresistance of esophageal squamous cell carcinoma[J]. Front Cell Dev Biol, 2022, 10: 792933. [14] WANG B, LI Y, SHAO C, et al. Cadmium and its epigenetic effects[J]. Curr Med Chem, 2012, 19(16): 2611-2620. [15] GU S Y, DAI J, QU T J, et al. Emerging roles of microRNAs and long noncoding RNAs in cadmium toxicity[J]. Biol Trace Elem Res, 2020, 195(2): 481-490. [16] CUI Z G, AHMED K, ZAIDI S F, et al. Ins and outs of cadmium-induced carcinogenesis: mechanism and prevention[J]. Cancer Treat Res Commun, 2021, 27: 100372. [17] ZHANG X P, WANG W, ZHU W D, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels[J]. Int J Mol Sci, 2019, 20(22): 5573. [18] WANG P S, WANG Z S, YANG C F. Dysregulations of long non-coding RNAs - the emerging lnc in environmental carcinogenesis[J]. Semin Cancer Biol, 2021, 76: 163-172. [19] ZHANG Y Y, GUO S Q, WANG S, et al. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling[J]. Ecotoxicol Environ Saf, 2021, 220: 112376. [20] LIN H P, WANG Z S, YANG C F. LncRNA DUXAP10 upregulation and the hedgehog pathway activation are critically involved in chronic cadmium exposure-induced cancer stem cell-like property[J]. Toxicol Sci, 2021, 184(1): 33-45. [21] HUANG Q H, LU Q, CHEN B X, et al. LncRNA-MALAT1 as a novel biomarker of cadmium toxicity regulates cell proliferation and apoptosis[J]. Toxicol Res, 2017, 6(3): 361-371. [22] ZHANG J P, LE T D, LIU L, et al. Inferring and analyzing module-specific lncRNA-mRNA causal regulatory networks in human cancer[J]. Brief Bioinform, 2019, 20(4): 1403-1419. [23] ZHAO Y F, HE J Y, ZHU T T, et al. Cadmium exposure reprograms energy metabolism of hematopoietic stem cells to promote myelopoiesis at the expense of lymphopoiesis in mice[J]. Ecotoxicol Environ Saf, 2022, 231: 113208. [24] GENCHI G, SINICROPI M S, LAURIA G, et al. The effects of cadmium toxicity[J]. Int J Environ Res Public Health, 2020, 17(11): 3782. [25] KULAS J, NINKOV M, TUCOVIC D, et al. Subchronic oral cadmium exposure exerts both stimulatory and suppressive effects on pulmonary inflammation/immune reactivity in rats[J]. Biomed Environ Sci, 2019, 32(7): 508-519. [26] CHEN X M, BI M Y, YANG J, et al. Cadmium exposure triggers oxidative stress, necroptosis, Th1/Th2 imbalance and promotes inflammation through the TNF-α/NF-κB pathway in swine small intestine[J]. J Hazard Mater, 2022, 421: 126704. [27] ZHOU X F, LI Y J, WANG W L, et al. Regulation of hippo/YAP signaling and esophageal squamous carcinoma progression by an E3 ubiquitin ligase PARK2[J]. Theranostics, 2020, 10(21): 9443-9457. [28] LIANG Z Z, ZHU R M, LI Y L, et al. Differential epigenetic and transcriptional profile in MCF-7 breast cancer cells exposed to cadmium[J]. Chemosphere, 2020, 261: 128148. [29] XU Q S, CHANG H Y, TIAN X R, et al. Hypoxia-induced MFAP5 promotes tumor migration and invasion via AKT pathway in head and neck squamous cell carcinoma[J]. J Cancer, 2020, 11(6): 1596-1605. [30] WU Z Q, WANG T, FANG M, et al. MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer[J]. Biochem Biophys Res Commun, 2018, 498(3): 495-501. [31] WU Y M, WU P, ZHANG Q, et al. MFAP5 promotes basal-like breast cancer progression by activating the EMT program[J]. Cell Biosci, 2019, 9: 24. [32] YEUNG T L, LEUNG C S, YIP K P, et al. Anticancer immunotherapy by MFAP5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer[J]. Clin Cancer Res, 2019, 25(21): 6417-6428. [33] AOKI S, INOUE K, KLEIN S, et al. Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma[J]. Gut, 2022, 71(1): 185-193. [34] PAGANI E, RUFFINI F, ANTONINI CAPPELLINI G C, et al. Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness[J]. Int J Oncol, 2016, 48(4): 1581-1589. [35] NAIK A, AL-ZEHEIMI N, BAKHEIT C S, et al. Neuropilin-1 associated molecules in the blood distinguish poor prognosis breast cancer: a cross-sectional study[J]. Sci Rep, 2017, 7(1): 3301. [36] 江文洋, 任杰, 梁健, 等. 上皮细胞膜蛋白2在食管癌中的表达及临床意义[J]. 实用医学杂志, 2015, 31(23): 3866-3868. |